This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Chesapeake, Health Net, Molson Coors, Ralph Lauren, Visteon Set to Report

Health Net ($42.64) spiked to a 52-week high at $45.61 on July 24, and declined to its 50-day SMA at $41.53, trading as low as $41 on Friday. The stock is well above its 200-day SMA at $34.53.

Analysts expect the company to report earnings of 56 cents per share. Health Net has a 12-month trailing P/E ratio of 21 and doesn't pay a dividend.

The weekly chart shifts to negative given a close this week below its five-week MMA at $41.85. Quarterly and semiannual value levels are $38.49 and $37.78, respectively, with a monthly pivot at $42.16 and weekly risky level at $44.12.

Ralph Lauren ($156.30) has been below its 200-day SMA at $161.57 since July 10, trading as low as $153.87 on Friday.

Analysts expect the company to report earnings of $1.75 per share. It has a 12-month trailing P/E ratio of 18.7 and dividend yield of 1.2%.

The weekly chart is negative with its five-week MMA at $157.06 and the 200-week SMA at $151.64. A monthly value level is $142.45 with an annual pivot at $154.30 and weekly and annual risky levels at $160.85 and $168.38, respectively.

Molson Coors ($67.90) set an all-time intraday high at $75.55 on June 20, and traded as low as $67 on Friday, which was well below its 50-day SMA at $70.77 and well above its 200-day SMA at $60.02.

Analysts expect the company to report earnings of $1.44 per share. It has 12-month trailing P/E ratio of 16.3 and dividend yield of 2.2%.

The weekly chart is negative with its five-week MMA at $69.75. Semiannual and annual value levels are $62.38 and $60.54, respectively, with a quarterly pivot is $67.88 and monthly and weekly risky levels at $71.00 and $76.99, respectively.

Visteon ($98.81) set an all-time intraday high at $100.79 on July 7, and traded as low as $94.23 on Thursday, compared with its 50-day SMA at $95.65. The stock is well above its 200-day SMA at $85.92.

Analysts expect the company to report earnings of 75 cents per share. It has a 12-month trailing P/E ratio of 22 and doesn't pay a dividend.

The weekly chart is neutral with its five-week MMA at $96.45 and its 200-week SMA down at $62.97. Semiannual value levels are $93.29 and $72.29, with a monthly pivot at $98.60 and weekly and quarterly risky levels at $99.29 and $107.56, respectively.

Abercrombie Is Seen on the Recovery Road

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
RL $135.95 -0.12%
TAP $73.65 -0.53%
AAPL $128.31 -0.50%
FB $78.80 -0.24%
GOOG $538.31 0.08%

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs